Transdermal Transmission Blocking Vaccine for Malaria using a Solid-in-Oil Dispersion

Area of Science:

• Immunology
• Vaccinology
• Parasitology

Background:

• Malaria remains a significant global health challenge, particularly in developing nations.
• Current malaria vaccines are typically administered via injection, posing challenges related to medical personnel requirements and infection risks.
• The stratum corneum's lipid-rich matrix presents a substantial barrier to the transdermal delivery of hydrophilic vaccine antigens.

Purpose of the Study:

• To design and evaluate a novel transdermal vaccine delivery system for Plasmodium vivax malaria.
• To assess the skin penetration efficacy of a solid-in-oil (S/O) dispersion compared to an aqueous solution.
• To determine the immunogenicity of the transdermal vaccine in a preclinical model.

Main Methods:

• Development of a solid-in-oil (S/O) dispersion incorporating the Pvs25 transmission-blocking vaccine candidate from Plasmodium vivax.
• Comparative assessment of skin penetration between the S/O dispersion and an aqueous solution.
• Immunization of mice with the transdermal vaccine and evaluation of antibody titers over time.

Main Results:

• The S/O dispersion demonstrated enhanced skin penetration compared to the aqueous solution.
• Mice immunized with the transdermal S/O vaccine achieved antibody titers comparable to those immunized via injection.
• Comparable mid- to long-term antibody responses were observed between transdermal and injectable immunization methods.

Conclusions:

• Solid-in-oil dispersion is a promising strategy for developing effective transdermal vaccines against vivax malaria.
• Transdermal vaccine administration offers a viable alternative to injections, potentially simplifying malaria prevention efforts.
• This research contributes to the advancement of malaria vaccine technology for disease eradication.